Shamburg News · 8-K filed Nov 12, 2026, 8:00 AM EST
ProMIS Neurosciences Posts Updated Corporate Presentation Under Regulation FD
PMN · ProMIS Neurosciences Inc.
- Reg FD disclosure
- Other event
- Materiality: low
On November 11, 2026, ProMIS Neurosciences Inc. posted an updated corporate presentation to its website and furnished it as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure). The presentation covers the PMN310 PRECISE-AD Phase 1b trial, including blinded interim data presented July 28, 2026, and anticipated 12-month topline data in Q1 2027. The filing states the information is furnished and not deemed filed for Exchange Act Section 18 purposes.
Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001104659-26-125896.
Written from the filing by Shamburg Markets. Figures are as reported by the company.